AI assistant
Sending…
PLUS THERAPEUTICS, INC. — Director's Dealing 2018
Feb 12, 2018
34301_dirs_2018-02-12_9c9df03b-d716-485f-88ba-1cab8fdc2bd2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2018-02-08
Reporting Person: PostFinance AG (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-02-08 | Common Stock | S | 228603 | $0.3431 | Disposed | 5311451 | Direct |
| 2018-02-09 | Common Stock | S | 7552 | $0.34 | Disposed | 5303899 | Direct |
More from PLUS THERAPEUTICS, INC.
Capital/Financing Update
2026
Jun 5
Regulatory Filings
2026
Jun 5
Capital/Financing Update
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Regulatory Filings
2026
Apr 21
Board/Management Information
2026
Apr 9
Regulatory Filings
2026
Apr 8
Board/Management Information
2026
Mar 26